Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
What compounding pharmacies are selling under its name is not the same drug that produced a 28.7% average weight loss in Eli Lilly's Phase 3 trial
Staheli, D.O
In limited cases where tirzepatide is prescribed for an FDA-approved indication such as obstructive sleep apnea, coverage and out-of-pocket costs vary by plan and are subject to change
Understanding the differences and how each option functions can help you make a more informed decision about your weight-loss plan
Weight loss results Research shows that people taking Zepbound lost 15% to 20% of their body weight over about 1.5 years (72 weeks)
Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, et al
US$ 23.26
US$ 28.47
US$ 26.43
